SCHEMBL6565574

SCHEMBL6565574

CC(C)Oc1ccc(F)cc1OCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.59
RAB9A P51151 9/20 0.56
NPC1 O15118 4/20 0.56
HPGD P15428 3/20 0.56
TSHR P16473 3/20 0.56
MAPK1 P28482 1/20 0.55
ALDH1A1 P00352 3/20 0.50
LMNA P02545 1/20 0.49
AGTR1 P30556 1/20 0.49
KMT2A Q03164 3/20 0.48
MEN1 O00255 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
MAPT P10636 1/20 0.44
ATM Q13315 1/20 0.44
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564387 0.88 RAB9A (0.67) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL6565624 0.86 L3MBTL1 (0.71) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL9631943 0.86 RAB9A (0.60) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL6565590 0.85 L3MBTL1 (0.59) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL9633218 0.85 RAB9A (0.59) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL9632000 0.85 RAB9A (0.59) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL6565588 0.84 L3MBTL1 (0.58) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL9632462 0.84 RAB9A (0.61) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL9633041 0.84 RAB9A (0.60) L3MBTL1RAB9ANPC1HPGDTSHR
SCHEMBL6564420 0.83 L3MBTL1 (0.57) L3MBTL1RAB9ANPC1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1135360-B1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PF MEDICAMENT (FR) 2004-03-31 EP disclosed
EP-1187824-B1 NOVEL (2-SUBSTITUTED-5 - 3-THIENYL) -BENZYL]- 2- ( 2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PF MEDICAMENT (FR) 2002-11-13 EP disclosed
US-6417222-B1 DRUGS FOR PSYCHOLOGICAL DISORDERS OR COGNITION ACTIVATORS PIERRE FABRE MEDICAMENT (FR) 2002-07-09 US disclosed
EP-1187824-A2 NOVEL (2-SUBSTITUTED-5 - 3-THIENYL) -BENZYL]- 2- ( 2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 2002-03-20 EP disclosed
EP-1135360-A1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PIERRE FABRE MEDICAMENT (FR) 2001-09-26 EP disclosed
WO-2000058282-A2 NOVEL [(2-SUBSTITUTED-5 -[3-THIENYL) -BENZYL]-[2- ([2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 2000-10-05 WO disclosed
WO-2000032557-A1 NOVEL 3-ALKOXYBENZYLAMINE DERIVATIVES AND THEIR USE AS MEDICINES FOR TREATING SCHIZOPHRENIA PIERRE FABRE MEDICAMENT (FR) 2000-06-08 WO disclosed